Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
January 17, 2024 9:30 PM 2 min read

Apple Watch Versions Minus Blood Oxygen Feature To Go On Sale In US As Cupertino Devises Way To Sidestep Looming Ban

by Ananya Gairola Benzinga Staff Writer
Follow

ArticleFeaturedTickersList12345!!!

In a response to a looming U.S. ban, Apple Inc. (NASDAQ:AAPL) has decided to release a variant of its latest watches without the blood oxygen feature, ensuring that sales in the country's market remain unaffected.

What Happened: Apple has taken out the blood oxygen feature from Apple Watch Series 9 and Apple Watch Ultra 2 models for sale in the U.S., reported CNBC on Wednesday. 

The decision comes in the wake of an intellectual property dispute with Masimo Corporation (NASDAQ:MASI), a medical device company, which led to a temporary halt on sales of Apple’s watches in the U.S. in December 2023. 

See Also: From Jon Favreau With 3D Dinosaurs To Alicia Keys’ Jam Session: Apple’s Vision Pro Originals Are Wild

The International Trade Commission had found that Apple’s blood oxygen watch sensors infringed upon patents held by Masimo. Although an injunction blocking the ban was lifted by an appeals court, the ITC’s decision is still being appealed. 

The modified watches will display an alert directing U.S. users to Apple’s website when they tap the blood oxygen icon. The lack of a blood oxygen sensor could potentially deter some customers.

“Pending the appeal, Apple is taking steps to comply with the ruling while ensuring customers have access to Apple Watch with limited disruption,” an Apple spokesperson told CNBC.

"These steps include introducing a version of Apple Watch Series 9 and Apple Watch Ultra 2 in the United States without the Blood Oxygen feature. There is no impact to Apple Watch units previously purchased that include the Blood Oxygen feature."

Why It’s Important: With the hope that the decision will be reversed, allowing the original watches back on the market, Apple could be facing a wait of over a year. In fiscal 2023, Apple reported a substantial $39.8 billion in wearables sales, the report noted. 

This latest move by Apple effectively mitigates the immediate threat posed to the sales of its latest smartwatch models. However, it’s crucial to note that this decision is not final and could be overturned if the ITC disputes it.

Image via Shutterstock

Check out more of Benzinga's Consumer Tech coverage by following this link.

Read Next: Microsoft Back On Top, Dethrones Apple As World's Most Valuable Company

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsTechMediaApple WatchAppleversebenzinga neuroConsumer Tech
MASI Logo
MASIMasimo Corp
$135.04-%
Overview
AAPL Logo
AAPLApple Inc
$275.650.05%
MASI Logo
MASIMasimo Corp
$135.04-%
Overview
AAPL Logo
AAPLApple Inc
$275.650.05%
Comments
Loading...